R 202001Z NOV 09
UNCLASSIFIED//
MARADMIN 0669/09
MSGID/GENADMIN,USMTF,2007/CMC WASHINGTON DC PPO//
SUBJ/GUIDANCE FOR ACTIVE AND RESERVE MARINE FORCES ON ADMINISTERING NOVEL H1N1 INFLUENZA VACCINE FOR 2009-2010//
REF/A/MSGID:DOC/ASD (HA) WASHINGTON DC/YMD:20090930//
REF/B/MSGID:MSG/BUMED WASHINGTON DC/081716ZSEP2009//
REF/C/MSGID:MSG/BUMED WASHINGTON DC/151652ZSEP2009//
REF/D/MSGID:MSG/BUMED WASHINGTON DC/231727ZOCT2009//
REF/E/MSGID:MSG/BUMED WASHINGTON DC/061534ZNOV2009//
REF/F/MSGID:MSG/BUMED WASHINGTON DC/231757ZOCT2009//
NARR/REF A PROVIDES POLICY GUIDANCE FROM THE ASSISTANT SECRETARY OF DEFENSE FOR HEALTH AFFAIRS (ASD (HA)) ON NOVEL H1N1 INFLUENZA NOVARTIS VACCINE ADMINISTRATION. REFS B THROUGH E COLLECTIVELY PROVIDE PROCEDURAL GUIDANCE FOR THE ACQUISITION, PRIORITIZATION, AND ADMINISTRATION OF THE NOVEL H1N1 INFLUENZA NOVARTIS VACCINE AND SANOFI-PASTEUR H1N1 INFLUENZA A VACCINE BY THE BUREAU OF MEDICINE AND SURGERY (BUMED). REF F PROVIDES BUMED GUIDANCE FOR GENERAL IMMUNIZATION PROGRAM COMPLIANCE.//
POC/SAUCEDA/HM1/UNIT:PPO, PORT/-/TEL:COMM 703-571-1048 /TEL:DSN 671-1048/EMAIL:LEE.SAUCEDA@USMC.MIL//
GENTEXT/REMARKS/1. THIS MARADMIN PROVIDES GUIDANCE FOR IMPLEMENTING THE 2009-2010 NOVEL H1N1 INFLUENZA VACCINATION PROGRAM. PER REF A, ALL MARINE CORPS FORCES (ACTIVE AND RESERVE) ARE REQUIRED TO RECEIVE THE NOVEL H1N1 INFLUENZA VACCINATION, USING THE NOVARTIS INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE, INCLUDING MARINES IN ACTIVE FLIGHT OR DIVE STATUS; MARINES WHO ARE PREGNANT OR BREAST FEEDING; AND MARINES WITH CHRONIC ILLNESS, UNLESS VACCINATION IS MEDICALLY CONTRAINDICATED (A CONDITION WHICH MAKES A STANDARD TREATMENT INADVISABLE). MISSION CRITICAL/MISSION ESSENTIAL DEPARTMENT OF DEFENSE (DOD) CIVILIANS AND CONTRACTORS SHOULD ALSO RECEIVE H1N1 VACCINATION.
2. BACKGROUND. THE 2009-H1N1 INFLUENZA VIRUS CONTINUES TO SPREAD AND IS THE DOMINANT INFLUENZA STRAIN CIRCULATING IN THE U.S. THE THREAT OF VIRAL MUTATION INTO A MORE VIRULENT (SERIOUS) INFLUENZA A STRAIN IS PERSISTENT. DOD HAS CONTRACTED TO RECEIVE 2.7 MILLION DOSES OF NOVARTIS INFLUENZA A (H1N1) 2009 MONOVALENT INJECTABLE VACCINE TO IMMUNIZE MILITARY (ACTIVE AND RESERVE) AND MISSION CRITICAL PERSONNEL (DOD CIVILIAN AND CONTRACTORS). THE DEFENSE LOGISTICS AGENCY DISTRIBUTION CENTER WAS TO DISTRIBUTE APPROXIMATELY 700K DOSES OF NOVARTIS VACCINE BY 9 NOV 2009, WITH THE REMAINDER DUE FOR DISTRIBUTION BEFORE 30 NOV 2009. THE MAJORITY OF THE FIRST DISTRIBUTION WILL GO TO DEPLOYED FORCES. THE NOVARTIS VACCINE MEETS THE NOVEL H1N1 IMMUNIZATION REQUIREMENT FOR ALL HEALTHY INDIVIDUALS AGES 18 TO 65. DOD CIVILIANS, MILITARY RETIREES, FAMILY MEMBERS, AND OTHER ELIGIBLE BENEFICIARIES WILL RECEIVE THE SANOFI-PASTEUR H1N1 INFLUENZA A VACCINE AS INDICATED FOR AGES ABOVE SIX MONTHS, AND FOR THOSE WHO HAVE MEDICAL CODITIONS ASSOCIATED WITH HIGHER RISK FROM INFLUENZA COMPLICATIONS.
3. EXECUTION. ALL COMMANDS AND INSTALLATIONS WILL COMPLETE THE H1N1 INFLUENZA IMMUNIZATION PROGRAM NLT 1 MAR 2010. COMMANDERS WILL IMMUNIZE ALL PERSONNEL AGAINST H1N1 PRIOR TO DEPLOYMENT. DELINQUENT AND NEW PERSONNEL (REPORTING AFTER 1 MAR 2010) WILL BE IMMUNIZED THROUGHOUT THE YEAR, DEPENDENT UPON VACCINE SUPPLIES.
4. SUPPLIES OF THE NOVARTIS INFLUENZA A (H1N1) VACCINE WILL BE PROVIDED TO MARINE FORCES IN GARRISON BY THE SERVICING MILITARY MEDICAL TREATMENT FACILITY (MTF). ALL MARINE FORCES IN THEATER SHOULD COORDINATE VACCINATION PLANS WITH THE APPROPRIATE COMBATANT COMMANDER. DOD CIVILIANS AND BENEFICIARIES MAY RECEIVE H1N1 VACCINATION AT ANY MILITARY MTF. EACH MTF HAS SANOFI-PASTEUR H1N1 VACCINE TO IMMUNIZE ALL DOD CIVILIANS AND OCONUS BENEFICIARIES. ELIGIBLE BENEFICIARIES IN CONUS MAY RECEIVE H1N1 IMMUNIZATION AT THE MTF FROM A NATIONAL STOCKPILE SUPPLIED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES. A VACCINE INFORMATION STATEMENT (VIS) WILL BE PROVIDED TO EACH VACCINEE. THE CENTERS FOR DISEASE CONTROL PUBLISHES A SEPARATE VIS FOR EACH VACCINE, ALL OF WHICH ARE AVAILABLE AT: WWW.CDC.GOV/VACCINES/PUBS/VIS/DEFAULT.HTM.
5. MEDICAL PERSONNEL SHALL ADHERE TO ALL MEDICAL GUIDELINES SPECIFIED WITHIN REFS B THROUGH F, AND SHALL REVIEW PRECAUTIONS FOR INDIVIDUALS WITH HYPERSENSITIVITY AND ALLERGY TO EGGS, EGG PRODUCTS (GELATIN), PRESERVATIVES AND/OR LATEX. IN THE EVENT OF AN ADVERSE REACTION, THE PROVIDER SHALL FILE A REPORT IN THE VACCINE ADVERSE EVENT REPORTING SYSTEM (VAERS). VAERS REPORT FORMS ARE AVAILABLE AT: HTTP:(SLASH SLASH)VAERS.HHS.GOV.
6. MEDICAL EXEMPTIONS. PER REF F (JOINT REGULATION GOVERNING IMMUNIZATION AND CHEMOPROPHYLAXIS), INDIVIDUALS WITH REPORTED HYPERSENSITIVITY TO VACCINE COMPONENTS/PACKAGING MATERIALS ARE DEFERRED FROM IMMUNIZATION. CASES OF HYPERSENSITIVITY SHALL BE DOCUMENTED WITHIN MEDICAL RECORDS AND IN THE MEDICAL READINESS REPORTING SYSTEM (MRRS). MEDICAL TEMPORARY (MT) EXEMPTION CODES ARE WARRANTED WHEN A PROVIDER HAS CONCERN ABOUT THE SAFETY OF THE IMMUNIZATION FOR MEMBERS WITH CERTAIN CLINICAL CONDITIONS. MEDICAL PERMANENT (MP) EXEMPTIONS ARE WARRANTED WHEN THE MEDICAL CONDITION OR ADVERSE REACTION IS SO SEVERE AND/OR UNREMITTING THAT THE RISK OF SUBSEQUENT IMMUNIZATION IS NOT JUSTIFIED. NO OTHER EXEMPTION CODES SHALL BE USED TO EXEMPT SERVICE MEMBERS FROM RECEIVING THE H1N1 INFLUENZA VACCINE.
7. ACTION. COMMANDERS SHALL ENSURE THAT ALL VACCINATIONS ARE PROPERLY DOCUMENTED IN EACH INDIVIDUAL HEALTH RECORD AND ENTERED INTO MRRS, TO FACILITATE DATA TRANSMISSION TO THE DEERS SYSTEM. MRRS PROVIDES DRILL DOWN CAPABILITY TO TRACK COMPLIANCE.
8. RELEASE AUTHORIZED BY LTGEN T. D. WALDHAUSER, DEPUTY COMMANDANT FOR PLANS, POLICIES, AND OPERATIONS.//